BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//College on Problems of Drug Dependence - CPDD - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:College on Problems of Drug Dependence - CPDD
X-ORIGINAL-URL:https://cpdd.org
X-WR-CALDESC:Events for College on Problems of Drug Dependence - CPDD
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231214T080000
DTEND;TZID=America/New_York:20240115T170000
DTSTAMP:20260405T004042
CREATED:20231214T152058Z
LAST-MODIFIED:20231214T152058Z
UID:13074-1702540800-1705338000@cpdd.org
SUMMARY:Call for Nominations: APA Div 28 Awards
DESCRIPTION:Call for Nominations: APA Div 28 Awards \nNominations are requested for the following 2024 APA Division 28 Awards: Outstanding Dissertation\, Early Career Psychopharmacologist\, and MED Associates Brady-Schuster. Candidates must be nominated by a Member or Fellow of Division 28\, and it is preferred but not required that nominees be a member of Division 28 and APA. Nominations of candidates from underrepresented minority groups are highly encouraged. \nNomination materials for each award are indicated below\, and should be emailed to ryi1@ku.edu (please put "Division 28 Nomination" in the subject line). Materials must be received no later than January 15\, 2024 \nOutstanding Dissertation Award honors the best doctoral dissertation in psychopharmacology and substance use. The award includes a cash prize\, funding support to attend the 2024 APA annual meeting\, and an engraved plaque. \nPersons who completed a doctoral program during calendar years 2022 or 2023 are eligible for nomination. The nomination must be based on a completed dissertation. Nominations must include: (1) a letter from the sponsor supporting the nomination; (2) a copy of the dissertation on which the nomination is based; and (3) any additional supporting documents.  \n Early Career Psychopharmacologist Award honors an early career scientist conducting original\, meritorious work in psychopharmacology and encourages excellence in research at the interface between the disciplines of pharmacology and psychology. The award includes a cash prize\, funding support to attend the 2024 APA annual meeting\, and an engraved plaque. \nPersons who are no more than ten (10) years past the date of receipt of the doctoral degree are eligible for nomination. The nomination must be based on work in an area of psychopharmacology\, behavioral pharmacology or substance use. Nominations must include: (1) the nominee's resume or Curriculum Vitae; (2) selected reprints or manuscript(s) describing the research on which the nomination is based; and (3) a statement from the sponsor in support of the nomination.  \nMED Associates Brady-Schuster Award honors a mid-career or senior scientist who conducts outstanding research underscoring the fundamental importance of behavioral science to psychopharmacology or substance use. The award includes a cash prize\, funding support to attend the 2024 APA annual meeting\, and an engraved plaque. \nPersons who are at least 15 years past the date of receipt of the doctoral degree and have an established record of outstanding contributions (in scholarship\, service\, and mentorship) in psychopharmacology\, behavioral pharmacology\, or substance use are eligible for nomination. \nNominations must include: (1) a letter detailing the nominee's scientific contributions; (2) the nominee's resume or Curriculum Vitae; and (3) selected reprints or manuscript(s) describing the research on which the nomination is based. 
URL:https://cpdd.org/event/call-for-nominations-apa-div-28-awards/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240117T130000
DTEND;TZID=America/New_York:20240117T143000
DTSTAMP:20260405T004042
CREATED:20240104T173914Z
LAST-MODIFIED:20240104T173914Z
UID:13114-1705496400-1705501800@cpdd.org
SUMMARY:NIH:  Upcoming Webinar: Looking Inward: Addressing the Stigma of Addiction
DESCRIPTION:NIH: Upcoming Webinar: Looking Inward: Addressing the Stigma of Addiction \nJoin presenters Dr. Wilson Compton\, Deputy Director of the National Institute on Drug Abuse (NIDA); Dr. Elizabeth Magnan\, Associate Professor of Family and Community Medicine at University of California\, Davis; Dr. Lisa Howley\, Senior Director for Transforming Medical Education at the Association of American Medical Colleges (AAMC); and Kamilah Weems\, MS\, Director of Strategic Initiatives and Partnerships at AAMC for a webinar on Wednesday\, January 17\, 2024\, from 1:00–2:15 pm ET. \nThe presenters will share findings from a new systematic literature review published in Academic Medicine\, the Journal of the AAMC\, exploring health care professionals’ bias and stigma related to addiction. The article focuses on understanding the extent to which health care provider bias and stigma around substance use disorders exist and identifying effective interventions that can help mitigate these factors. Panelists will also provide updates on several national education efforts on substance use disorder training and discuss the state of the addiction crisis. \nRegister Here
URL:https://cpdd.org/event/nih-upcoming-webinar-looking-inward-addressing-the-stigma-of-addiction/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240127T080000
DTEND;TZID=America/New_York:20240201T170000
DTSTAMP:20260405T004042
CREATED:20230421T192231Z
LAST-MODIFIED:20230421T192231Z
UID:11536-1706342400-1706806800@cpdd.org
SUMMARY:Winter Conference on Brain Research
DESCRIPTION:
URL:https://cpdd.org/event/winter-conference-on-brain-research-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240131T080000
DTEND;TZID=America/New_York:20240214T170000
DTSTAMP:20260405T004042
CREATED:20240214T142009Z
LAST-MODIFIED:20240214T142009Z
UID:13191-1706688000-1707930000@cpdd.org
SUMMARY:Assessment of Substance Use Disorder Stigma and Strategies for Addressing Stigma in Rural Areas
DESCRIPTION:
URL:https://cpdd.org/event/assessment-of-substance-use-disorder-stigma-and-strategies-for-addressing-stigma-in-rural-areas/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240219T080000
DTEND;TZID=America/New_York:20240219T170000
DTSTAMP:20260405T004042
CREATED:20240208T214548Z
LAST-MODIFIED:20240208T214548Z
UID:13176-1708329600-1708362000@cpdd.org
SUMMARY:International Committee Welcome Meeting
DESCRIPTION:International Committee Welcome Meeting\nMonday\, February 19\, 2024 at 5:00 PM EST \nAre you thinking about attending the 86th Annual CPDD Scientific Meeting in Montreal\, or perhaps you’ve already registered but are navigating it for the first time? Maybe you've been with us before but felt a bit out of the loop? \nWe’ve all been there! That's precisely why the CPDD International Committee is thrilled to invite you to our Welcome Meeting\, designed just for you. Join us on Monday\, February 19\, from 5-6pm EST [convert this time to your local zone easily via this link]. \nIn this hour\, we aim to provide you with: \n\nGuidance on financial support/discount options to make meeting attendance more accessible.\nInformation about hotel room sharing options to ease your stay.\nEssential Canadian travel information.\nInstructions on obtaining a Visa Invitation Letter from CPDD.\nMore than that\, we want to share our experiences - the hurdles we overcame to make every CPDD meeting feel like coming home\, fostering a space where you can form lasting connections and collaborations.\n\nHere's the Zoom link for the event: https://us02web.zoom.us/j/89245484211 (Meeting ID: 892 4548 4211). \nAny questions? Reach out to the International Committee chair Laura Brandt @ lbrandt@ccny.cuny.edu \nP.S. Not an international attendee but intrigued by what we're offering? Our mission extends to building bridges for collaboration between international and US-based researchers. Feel free to join us at the Welcome Meeting and look out for our international networking zone at this year’s CPDD meeting for more opportunities to connect and collaborate. \n 
URL:https://cpdd.org/event/international-committee-welcome-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240228T080000
DTEND;TZID=America/New_York:20240301T170000
DTSTAMP:20260405T004042
CREATED:20230829T204924Z
LAST-MODIFIED:20230829T204924Z
UID:12117-1709107200-1709312400@cpdd.org
SUMMARY:2024 Psychiatric Research Society 62nd Annual Meeting for Circulation
DESCRIPTION:2024 Psychiatric Research Society 62nd Annual Meeting for Circulation \nWhen: February 28 - March 1\, 2024 in \nWhere: Sheraton Park City\, Park City\, Utah or Virtually\, This meeting is hybrid. \nSubmissions open now until September 22nd. \nRegistration opens September 12th for in-person and virtual attendees. \nMeeting Website:  http://www.psychiatricresearchsociety.org/ \nSubmissions are currently being accepted with the deadline of September 22nd \n\nGenetic studies in psychiatry\nHow artificial intelligence influences science\nMechanisms of mental health disparities\nSleep and circadian function in the development of mental health and substance use problems\nTranslational approaches to understanding the intersection of puberty in neurodevelopment\,  brain development\, and psychopathology\nUse of psychedelic and dissociative drugs for psychiatric treatment advances in Pharmacological Management\nDiversity\, equity\, and inclusivity in clinical psychiatry research\nPredictors of treatment response\nNeurodevelopment and its relationship to the expression of psychopathology
URL:https://cpdd.org/event/2024-psychiatric-research-society-62nd-annual-meeting-for-circulation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240305T130000
DTEND;TZID=America/New_York:20240305T140000
DTSTAMP:20260405T004042
CREATED:20240213T215250Z
LAST-MODIFIED:20240213T215250Z
UID:13188-1709643600-1709647200@cpdd.org
SUMMARY:Media Training with Reporting on Addiction Webinar
DESCRIPTION:Media Training with Reporting on Addiction Webinar\nJoin Us for a Media Training with Reporting on Addiction Webinar \nMarch 5\, 2023\, at 1:00 PM ET\nA virtual webinar focused on “Media Training with Reporting on Addiction” will be hosted by the Communications Committee and led by Jonathan Stoltman and Ashton Marra\, co-directors of Reporting on Addiction. The webinar will provide tips on communicating science effectively and working with the media to share your research accurately and concisely. Recommendations for working with journalists\, including pitching ideas and op-eds\, will also be reviewed.
URL:https://cpdd.org/event/media-training-with-reporting-on-addiction-webinar/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240307
DTEND;VALUE=DATE:20240310
DTSTAMP:20260405T004042
CREATED:20240103T215512Z
LAST-MODIFIED:20240103T221836Z
UID:13109-1709769600-1710028799@cpdd.org
SUMMARY:APPA 2024 Annual Meeting
DESCRIPTION:Confirmed speakers:  Neil K. Aggarwal\, Margarita Alegría\, Deidre Anglin\, Anne Becker\, Carlos Blanco\, Christina Borba\, Joshua Breslau\, Pamela Collins\, Adolfo Cuevas\, Cristiane Duarte\, Erin Dunn\, Joseph Gone\, Sidney Hankerson\, Helena Hansen\, Mark Hatzenbuehler\, Nev Jones\, Katherine Keyes\, Lisa Kiang\, Laurence Kirmayer\, Rachel Kronick\, Roberto Lewis-Fernández\, Michael Lindsey\, Bruce Link\, Chackupurackal Mathai\, Kieran O’Donnell\, Ruth Shim\, Jennifer Stevens\, and Lawrence Yang. \nRegistration is now open for the 2024 APPA Annual Meeting.  \nEarly-bird registration closes on January 12\, 2024\, so register now! \nIn 2024\, APPA will be returning to the Martinique New York Hotel on Broadway: just two blocks from Herald Square and next door to the Empire State building\, we’ll be in the heart of the city. \nNew for 2024: registration rates are bundled with APPA membership! Everyone who registers for the meeting will become a member of APPA and will have access to our members-only content at www.appassn.org – including meeting materials and webinar recordings.\n\nCLICK HERE FOR ADDITIONAL INFORMATION AND TO REGISTER
URL:https://cpdd.org/event/appa-2024-annual-meeting/
CATEGORIES:CPDD Webinars,Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240309T080000
DTEND;TZID=America/New_York:20240310T170000
DTSTAMP:20260405T004042
CREATED:20230831T164035Z
LAST-MODIFIED:20230831T164035Z
UID:12145-1709971200-1710090000@cpdd.org
SUMMARY:ASCP 2024 Spring Virtual Meeting
DESCRIPTION:
URL:https://cpdd.org/event/ascp-2024-spring-virtual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240411T080000
DTEND;TZID=America/New_York:20240414T170000
DTSTAMP:20260405T004042
CREATED:20230829T205301Z
LAST-MODIFIED:20230829T205301Z
UID:12119-1712822400-1713114000@cpdd.org
SUMMARY:ADAA 2024 Annual Conference for Cross Promotion
DESCRIPTION:  \n  \nMeeting Website:  ADAA 2024 Anxiety and Depression Conference
URL:https://cpdd.org/event/adaa-2024-annual-conference-for-cross-promotion/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240416T123000
DTEND;TZID=America/New_York:20240416T133000
DTSTAMP:20260405T004042
CREATED:20240214T204415Z
LAST-MODIFIED:20240214T204415Z
UID:13194-1713270600-1713274200@cpdd.org
SUMMARY:NABR Webinar: “One Health and Animal Research: The Good\, the Bad\, and the Ugly”
DESCRIPTION:NABR Webinar:“One Health and Animal Research: The Good\, the Bad\, and the Ugly” \nPlease join us on Tuesday\, April 16th\, at 12:30 p.m. EST when Jerrold Tannenbaum returns to our webinar series with a presentation titled: “One Health and Animal Research: The Good\, the Bad\, and the Ugly.” “One Health” is today the most influential organizing concept in the medical sciences. From the American Veterinary Medical Association\, to the American Medical Association\, to the World Health Organization\, One Health is proclaimed — and virtually universally accepted — as both the primary goal of\, and the underlying methodological approach used in medical and veterinary research\, education\, and practice. \nThis webinar will describe the crucial role laboratory animal research played in the development of the concept of One Medicine\, the historical precursor of One Health. The discussion will review differing approaches to One Health and will discuss how biomedical animal research can be an important component of some of these approaches. The webinar will also highlight current approaches to One Health that provide challenges to laboratory animal research. These include the increasing use of privately owned animals\, mainly pet cats and dogs\, in clinical studies and trials. Of greater concern are approaches to One Health that diminish the importance of human and animal research that benefits human health; would require the diversion of critical resources away from animal research; incorporate concepts of “health” (such as environmental health\, ecosystem health\, or planetary health) that are unhelpful and may be incoherent; and include societal or geopolitical considerations that have no clear connection to science-driven biomedical research. \nThe webinar will examine how the biomedical research community can recognize\, and counter approaches to One Health that are inimical to or threaten animal research. The discussion will suggest ways the community can support and engage in approaches to One Health that appropriately benefit people\, animals\, and the environment. \nRegistration for the webinar is available here. \n​​​​​​
URL:https://cpdd.org/event/nabr-webinar-one-health-and-animal-research-the-good-the-bad-and-the-ugly/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240416T123000
DTEND;TZID=America/New_York:20240416T133000
DTSTAMP:20260405T004042
CREATED:20240405T205655Z
LAST-MODIFIED:20240405T205655Z
UID:13360-1713270600-1713274200@cpdd.org
SUMMARY:NABR Webinar: “One Health and Animal Research: The Good\, the Bad\, and the Ugly”
DESCRIPTION:NABR Webinar:“One Health and Animal Research: The Good\, the Bad\, and the Ugly” \nPlease join us on Tuesday\, April 16th\, at 12:30 p.m. EST when Jerrold Tannenbaum returns to our webinar series with a presentation titled: “One Health and Animal Research: The Good\, the Bad\, and the Ugly.” “One Health” is today the most influential organizing concept in the medical sciences. From the American Veterinary Medical Association\, to the American Medical Association\, to the World Health Organization\, One Health is proclaimed — and virtually universally accepted — as both the primary goal of\, and the underlying methodological approach used in medical and veterinary research\, education\, and practice. \nThis webinar will describe the crucial role laboratory animal research played in the development of the concept of One Medicine\, the historical precursor of One Health. The discussion will review differing approaches to One Health and will discuss how biomedical animal research can be an important component of some of these approaches. The webinar will also highlight current approaches to One Health that provide challenges to laboratory animal research. These include the increasing use of privately owned animals\, mainly pet cats and dogs\, in clinical studies and trials. Of greater concern are approaches to One Health that diminish the importance of human and animal research that benefits human health; would require the diversion of critical resources away from animal research; incorporate concepts of “health” (such as environmental health\, ecosystem health\, or planetary health) that are unhelpful and may be incoherent; and include societal or geopolitical considerations that have no clear connection to science-driven biomedical research. \nThe webinar will examine how the biomedical research community can recognize\, and counter approaches to One Health that are inimical to or threaten animal research. The discussion will suggest ways the community can support and engage in approaches to One Health that appropriately benefit people\, animals\, and the environment. \nRegistration for the webinar is available here. \n​​​​​​
URL:https://cpdd.org/event/nabr-webinar-one-health-and-animal-research-the-good-the-bad-and-the-ugly-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240423T080000
DTEND;TZID=America/New_York:20240423T170000
DTSTAMP:20260405T004042
CREATED:20231201T205947Z
LAST-MODIFIED:20231201T205947Z
UID:13023-1713859200-1713891600@cpdd.org
SUMMARY:6th Annual Substance Use Research Event
DESCRIPTION:
URL:https://cpdd.org/event/6th-annual-substance-use-research-event/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240617T080000
DTEND;TZID=America/New_York:20240618T170000
DTSTAMP:20260405T004042
CREATED:20231206T185236Z
LAST-MODIFIED:20231206T185236Z
UID:13053-1718611200-1718730000@cpdd.org
SUMMARY:ESLAV-ECLAM-AAALAC Conference\, 17-18 June 2024
DESCRIPTION:Save The Date! \nConference website: https://eslav-eclam-aaalac-conference2024.eu/en/welcome/The joint ESLAV-ECLAM-AAALAC Conference will be held on 17-18 June 2024 in Amsterdam. The conference will be followed by the ESLAV-ECLAM Summer School\, 19-21 June\, also in Amsterdam. Additional details on the conference venue\, exhibiting\, abstracts and more will be shared on the conference website.
URL:https://cpdd.org/event/eslav-eclam-aaalac-conference-17-18-june-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240619T080000
DTEND;TZID=America/New_York:20240621T170000
DTSTAMP:20260405T004042
CREATED:20240318T163840Z
LAST-MODIFIED:20240318T163840Z
UID:13287-1718784000-1718989200@cpdd.org
SUMMARY:ISSDP 2024 Conference
DESCRIPTION:
URL:https://cpdd.org/event/issdp-2024-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240716T123000
DTEND;TZID=America/New_York:20240716T133000
DTSTAMP:20260405T004042
CREATED:20240529T161038Z
LAST-MODIFIED:20240529T161038Z
UID:13492-1721133000-1721136600@cpdd.org
SUMMARY:NABR Webinar: Q&A With the USDA - The 12th Edition
DESCRIPTION:NABR Webinar: Q&A With the USDA - The 12th Edition \nNABR is once again pleased to announce the return of one of its most requested webinars\,  "Q&A with the USDA." Join USDA-APHIS Animal Care’s Drs. Elizabeth Theodorson\, assistant deputy administrator for Animal Welfare Operations\, and Dr. Louis DiVincenti\, senior veterinary medical officer -research\, for "Q&A with the USDA: The 12th Edition” on Tuesday\, July 16 at 12:30 p.m. EDST. \nAs in the past this webinar will provide NABR members with a unique opportunity to ask questions directly of the leadership of Animal Care’s Animal Welfare Operations. A lot has changed in the last year. The final rule on Standards for Birds Not Bred for Use in Research Under the Animal Welfare Act was implemented\, the Animal Welfare Inspection Guide was revised\, and the USDA and Justice Department entered into a Memorandum of Understanding on Civil Enforcement of the Animal Welfare Act. You should take advantage of this unique opportunity provided to NABR members to better understand what impact these and other ongoing changes may have on your institution concerning compliance with the Animal Welfare Regulations. \nQuestions should be submitted in advance to info@nabr.org. They will be reviewed and formatted to prevent duplication and will be answered in the order they are received\, so please submit them as soon as possible. As in the past we will schedule the session for an hour but will continue the webinar until all questions have been addressed. \nRegistration is available here. \n​​​​​​
URL:https://cpdd.org/event/nabr-webinar-qa-with-the-usda-the-12th-edition/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240723T130000
DTEND;TZID=America/New_York:20240723T140000
DTSTAMP:20260405T004042
CREATED:20240715T144054Z
LAST-MODIFIED:20240717T123643Z
UID:13530-1721739600-1721743200@cpdd.org
SUMMARY:Introduction to FDA’s Office of Trade and Global Partnerships
DESCRIPTION:Introduction to FDA’s Office of Trade and Global Partnerships \nJuly 23\, 2024 – Webinar\nIntroduction to FDA’s Office of Trade and Global Partnerships \nLearn about the FDA’s Office of Trade and Global Partnerships (OTGP) and how its work relates to pharmaceutical products. This discussion will also cover the different types of international agreements and arrangements used by the FDA. \n\n\n\nLinkedIn: SBIA|Webinar: July 23\, 2024 – Introduction to FDA’s Office of Trade and Global Partnerships\nX: SBIA|Webinar: July 23\, 2024 – Introduction to FDA’s Office of Trade and Global Partnerships
URL:https://cpdd.org/event/introduction-to-fdas-office-of-trade-and-global-partnerships/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240730T140000
DTEND;TZID=America/New_York:20240730T150000
DTSTAMP:20260405T004042
CREATED:20240715T144226Z
LAST-MODIFIED:20240715T144226Z
UID:13531-1722348000-1722351600@cpdd.org
SUMMARY:Environmental Monitoring in Compounding
DESCRIPTION:Environmental Monitoring in Compounding \nJuly 30\, 2024 – Webinar\nEnvironmental Monitoring in Compounding \nGet an overview of environmental monitoring for compounding facilities and the role it plays in ensuring product quality and patient safety. Presenters will discuss statutory and regulatory requirements\, expectations for compounding pharmacies and outsourcing facilities\, and different methods specific to environmental monitoring. \n\n\n\nLinkedIn: SBIA|Webinar: July 30\, 2024 – Environmental Monitoring in Compounding\nX: SBIA|Webinar: July 30\, 2024 – Environmental Monitoring in Compounding
URL:https://cpdd.org/event/environmental-monitoring-in-compounding/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240911T130000
DTEND;TZID=America/New_York:20240911T140000
DTSTAMP:20260405T004042
CREATED:20240903T144036Z
LAST-MODIFIED:20240903T144036Z
UID:13616-1726059600-1726063200@cpdd.org
SUMMARY:Next National Advisory Council on Drug Abuse Meeting: September 11
DESCRIPTION:Next National Advisory Council on Drug Abuse Meeting: September 11 \nThe National Advisory Council on Drug Abuse (NACDA) serves a crucial role in advising NIDA\, and\, by extension\, the Director\, NIH and the Secretary\, DHHS\, as NIDA identifies\, reviews\, and supports the highest caliber of scientific research. \nThe next NACDA meeting will take place Wednesday\, September 11\, 2024. Additional details and a link to the videocast are available here. \n\n\n\n\n\n\n\nJoin the Videocast on Sept. 11
URL:https://cpdd.org/event/next-national-advisory-council-on-drug-abuse-meeting-september-11/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240912T083000
DTEND;TZID=America/New_York:20240912T180000
DTSTAMP:20260405T004042
CREATED:20240715T144528Z
LAST-MODIFIED:20240715T144528Z
UID:13532-1726129800-1726164000@cpdd.org
SUMMARY:Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024
DESCRIPTION:Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 \nSeptember 12\, 2024 ­– Webinar\n8:45 am-5:45pm \nElectronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 \nThis demonstration of how to submit establishment registration and drug listing data using CDER Direct will feature case studies for an interactive learning experience. \n\n\n\nLinkedIn: SBIA|Webinar: September 12\, 2024 – Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024\nX: SBIA|Webinar: September 12\, 2024 – Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024
URL:https://cpdd.org/event/electronic-drug-registration-and-listing-edrls-using-cder-direct-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240927T130000
DTEND;TZID=America/Los_Angeles:20240927T163000
DTSTAMP:20260405T004042
CREATED:20240924T201352Z
LAST-MODIFIED:20240924T201404Z
UID:13665-1727442000-1727454600@cpdd.org
SUMMARY:Sex Differences in Addiction Workshop
DESCRIPTION:Sex Differences in Addiction Workshop  \nOrganized in conjunction with ACU’s Healthy Brain and Mind Research Centre\, experts from the National Institute on Drug Abuse\, and the ENIGMA consortium \nWhen: Friday 27 September 2024 (1pm – 4.30pm PDT\, see other timezones)\nWhere: Online via Zoom\nRegistration: https://forms.gle/LxCPPCPUVtpHL24n9\nFind more info at: https://enigma.ini.usc.edu/events/upcoming-events/ \nErynn\, on behalf of the Sex Differences in Addiction Organising Committee:  Isabella Goodwin\, ACU; Dr Erynn Christensen\, Feinstein Institutes for Medical Research; Dr Sophia Thomopoulos\, University of Southern California; Prof Rita Valentino\, NIDA; & A/Prof Valentina Lorenzetti\, ACU (Chair) 
URL:https://cpdd.org/event/sex-differences-in-addiction-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241008T123000
DTEND;TZID=America/New_York:20241008T133000
DTSTAMP:20260405T004042
CREATED:20240814T144054Z
LAST-MODIFIED:20240814T144054Z
UID:13587-1728390600-1728394200@cpdd.org
SUMMARY:NABR Webinar: “Current and Future Challenges Facing Biomedical Research”
DESCRIPTION:NABR Webinar: “Current and Future Challenges Facing Biomedical Research” \nPlease join us on Tuesday\, Oct. 8\, at 12:30 p.m. EST for the 61st NABR webinar when Matt Bailey\, President of NABR and FBR; Brandon Morton\, NABR’s Director of Government Affairs; and Taylor Bennett\, NABR’s Senior Scientific Advisor\, sit down to discuss the “Current and Future Challenges Facing Biomedical Research.” NABR is the only national nonprofit organization dedicated solely to advocating for sound public policy that recognizes the vital role animals play in biomedical research. In that role\, NABR provides the unified voice for the scientific community on legislative and regulatory matters affecting laboratory animal research at the federal level. FBR provides valuable communication expertise promoting public understanding and support for biomedical research to address the challenges and variety of tactics used by those opposed to animals in biomedical research. These tactics include calling into question the validity of animal models\, the money spent to support that research\, an increased number of legislative efforts at the federal\, state and local level and targeted campaigns against specific areas of research. In addition\, these groups have effectively weaponized the use of FOIA and state open records acts to target institutions and individuals. In this webinar\, recent legislative and regulatory issues will be reviewed\, and animal rights campaigns will be highlighted to share lessons learned for addressing the challenges facing the research community. \nRegister:  https://register.gotowebinar.com/register/1681185605630712411 
URL:https://cpdd.org/event/nabr-webinar-current-and-future-challenges-facing-biomedical-research/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241015T080000
DTEND;TZID=America/New_York:20241016T170000
DTSTAMP:20260405T004042
CREATED:20241014T212216Z
LAST-MODIFIED:20241014T212216Z
UID:13723-1728979200-1729098000@cpdd.org
SUMMARY:Professional NIH Grant Development Live Online Workshop
DESCRIPTION:Professional NIH Grant Development Live Online Workshop\nOctober 15-16\, 2024\n10:30 a.m. to 6:00 p.m. Eastern Time\nSponsored by the Grant Training Center \nThe Professional NIH Grant Development live online workshop\, which is normally held at the University of Pennsylvania\, has moved online. It will include the same content and length of instruction. \nYou will learn how to: \n\nMake the match with the appropriate NIH institute\, program and grant mechanism\nIdentify and avoid common pitfalls of a grant\nWrite exceptional Specific Aims pages\nEffectively address each piece of the application\nUnderstand the review process and successfully write for reviewers\nComprehend what happens in the study section\nDecipher pink sheets: The inevitable resubmission\nBuild an airtight case for funding\n\nOur ultimate goal is for you to walk away with a product specific to your interests. \nRegister  \nWorkshop Fee: $595.00\nIncludes a comprehensive list of resources\, workbook\, and certificate of completion \nRebate of $45.00 per person\nFor two or more registrants from the same organization \nCan't make this session?\nSelf-paced NIH course\nto fit any schedule \nFollow-up workshop on dissecting full proposals through expert feedback enhances chances of success\nReviewing and Refining Your NIH Proposal\nOctober 17\, 2024 \nSince this class fills up quickly\, it is on a first-come\, first serve basis \nRegister for our membership and a workshop and receive a $50 rebate. Only the highest discount will apply. \nQuestions? Call (866) 704-7268.
URL:https://cpdd.org/event/professional-nih-grant-development-live-online-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241018
DTEND;VALUE=DATE:20241024
DTSTAMP:20260405T004042
CREATED:20240715T151322Z
LAST-MODIFIED:20240715T151412Z
UID:13533-1729209600-1729727999@cpdd.org
SUMMARY:NAADAC 2024 Annual Conference & Hill Day
DESCRIPTION:FROM THE NAADAC WEBSITE: \nRegistration Information for the NAADAC 2024 Annual Conference & Hill Day \n \nJoin us for the NAADAC 2024 Annual Conference & Hill Day: Learn\, Connect\, Advocate\, Succeed\, in the Washington\, DC\, area at the Gaylord National Resort & Convention Center from October 18 - 23\, 2024. \nThis year's conference will feature dozens of educational sessions presented by nationally recognized speakers\, an exhibit hall\, networking opportunities\, and so much more! Register now! \nThree-Day Conference Registration   |  One-Day Registration   |   Special Events Registration   |   Registration Cancellation Policy    |   Pre-Conference Registration    |   Post-Conference Registration \n 
URL:https://cpdd.org/event/naadac-2024-annual-conference-hill-day/
LOCATION:Washington DC
CATEGORIES:Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241021T090000
DTEND;TZID=America/New_York:20241021T163000
DTSTAMP:20260405T004042
CREATED:20240924T134222Z
LAST-MODIFIED:20240924T134222Z
UID:13658-1729501200-1729528200@cpdd.org
SUMMARY:FDA and NIH Joint Public Meeting on Advancing Smoking Cessation Priorities
DESCRIPTION:FDA and NIH Joint Public Meeting on Advancing Smoking Cessation Priorities\nREGISTRATION IS OPEN \nOn Monday\, October 21\, from 9 a.m. to 4:30 p.m. EDT\, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will host a joint public meeting entitled\, “Advancing Smoking Cessation: FDA and NIH Priorities.” The focus of the meeting is on advancing innovation of smoking cessation products to help both adults and youth. \nThe meeting will feature presentations and panel discussions on several smoking cessation-focused topics\, including:\n• Clinical and community perspectives\n• Promising target areas for development\n• Regulatory paths forward \nThe meeting will include an opportunity for public comment on several topics related to cessation. \nThe meeting is free\, and can be attended virtually or in-person at the FDA’s White Oak campus in Silver Spring\, Maryland. Additional information about the meeting\, including specific questions for which public comment is being sought\, is found in the Federal Register notice announcing the meeting. Deadlines for registration\, including for public comment\, are as follows:\n• In-person registration is required by October 15\, 2024\, while virtual registration is open through 9:00 a.m. EDT on the day of the meeting.\n• Registration to speak in-person during the public comment portion of the meeting is required by October 1 at 5:00 p.m. EDT. Please note that public comments during the meeting will only be accepted in person and not virtually. Every effort will be made to accommodate as many speakers as possible; however\, speaking spots are limited and not guaranteed.\n• Written comments must be submitted by November 21\, 2024 via the meeting's public docket on Regulations.gov [Docket No. FDA-2024-N-4085]. \nTobacco product use remains the single most preventable cause of disease\, disability and death in the United States\, and each year\, an estimated 480\,000 Americans die prematurely from smoking or from exposure to second-hand smoke. The U.S. Department of Health and Human Services (HHS) Framework to Support and Accelerate Smoking Cessation includes a stated goal to promote ongoing and innovative research in the area of cessation. The FDA and NIH’s joint October meeting is in support of these efforts\, as the Department advances our collective efforts to improve the nation’s health. \nRegister Now \n  \n  \n 
URL:https://cpdd.org/event/fda-and-nih-joint-public-meeting-on-advancing-smoking-cessation-priorities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241021T090000
DTEND;TZID=America/New_York:20241021T163000
DTSTAMP:20260405T004042
CREATED:20241008T164930Z
LAST-MODIFIED:20241008T164930Z
UID:13698-1729501200-1729528200@cpdd.org
SUMMARY:Advancing Smoking Cessation: FDA and NIH Priorities
DESCRIPTION:Advancing Smoking Cessation: FDA and NIH Priorities \nAttend the joint public meeting hosted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). \nGoals and Objectives:  This public meeting will address the need for novel smoking cessation products to help individuals of all ages\, including underserved and vulnerable populations\, stop smoking. The overall goal of the meeting is to stimulate novel product development to reduce rates of smoking and related chronic illnesses. The meeting format will include presentations and panel discussions. \nIn-person Attendance Information: This meeting will be held at the FDA White Oak Campus in the Great Room. Address: 10903 New Hampshire Avenue Bldg. 31\, Room 1503\, Silver Spring\, MD 20903 \nThe FDA will make every effort to accommodate persons with physical disabilities or special needs at public meetings. If a reasonable accommodation is needed\, please indicate accordingly during registration and email TobaccoCessation@fda.hhs.gov. Requests for sign language interpretation should be made at least 7 days before the public meeting. A request for ASL services should be sent directly to the FDA Interpreting Services Staff email account: interpreting.services@fda.hhs.gov. The FDA White Oak campus and FDA shuttle are generally accessible to people with physical disabilities. \nAdditional information to assist with in-person attendance may be found within the following webpages: Public Meeting Information\, Getting to the FDA\, and Visitor Parking and Campus Map. \nVirtual Attendance Information: The Zoom link will be provided to all registered attendees before the meeting. Virtual attendees can join the meeting by computer or phone. \nInterested in submitting a request to make an oral presentation during the meeting? \nIndividuals attending the meeting in person may submit requests to make oral presentations at the public meeting. Select “In-person registration with presentation request\,” follow the instructions presented in the confirmation email\, and submit all details by 5 p.m. EDT\, October 1\, 2024. \nContact: For additional details and questions contact the meeting support team at TobaccoCessation@fda.hhs.gov. \nPlease note: In addition to this public meeting\, the public can submit electronic or written comments to the docket until November 21\, 2024\, at 11:59 p.m. Eastern Time. Please visit the Federal Register Notice for the “Advancing Smoking Cessation: FDA and NIH Priorities” for more information about submitting comments.
URL:https://cpdd.org/event/advancing-smoking-cessation-fda-and-nih-priorities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250116T120000
DTEND;TZID=America/New_York:20250116T130000
DTSTAMP:20260405T004042
CREATED:20250102T153922Z
LAST-MODIFIED:20250106T204212Z
UID:13980-1737028800-1737032400@cpdd.org
SUMMARY:NEW DATE - FDA Grand Rounds on The PATH from Data to Action
DESCRIPTION:Join January 16 FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health Study to Inform FDA’s Regulatory Activities \nThe Population Assessment of Tobacco and Health (PATH) Study\, a national\, longitudinal cohort study of tobacco use and health in the United States\, is one of the first large tobacco research efforts undertaken by FDA Center for Tobacco Products (CTP) and National Institute of Health (NIH) after Congress gave FDA authority to regulate tobacco products in 2009. \nThis presentation will share an overview and history of the PATH Study\, evolution of the study design made over time in response to important changes in tobacco marketplace and regulatory environment and highlight how its designs and findings can inform tobacco regulatory science and public health. \nWhen: Thursday January 16\, 2025; 12:00 p.m. - 1:00 p.m. ET \nRegister for Webinar:  https://www.fda.gov/science-research/fda-grand-rounds/fda-grand-rounds-path-data-action-key-findings-population-assessment-tobacco-and-health-path-study?utm_campaign=ctp-sos&utm_content=event&utm_medium=email&utm_source=govdelivery&utm_term=stratcomms#event-information \n  \n 
URL:https://cpdd.org/event/fda-grand-rounds-on-the-path-from-data-to-action/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250130T140000
DTEND;TZID=America/New_York:20250130T150000
DTSTAMP:20260405T004042
CREATED:20250113T194124Z
LAST-MODIFIED:20250113T194124Z
UID:14021-1738245600-1738249200@cpdd.org
SUMMARY:Demystifying Medications for Substance Use Disorder
DESCRIPTION:January 30 | Demystifying Medications for Substance Use Disorder @ 2 p.m. ET\nSave the date for this upcoming event! \nhttps://www.samhsa.gov/about/digital-toolkits/substance-use-disorder-treatment-month
URL:https://cpdd.org/event/demystifying-medications-for-substance-use-disorder/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250206T130000
DTEND;TZID=America/New_York:20250206T140000
DTSTAMP:20260405T004042
CREATED:20250115T193234Z
LAST-MODIFIED:20250115T193234Z
UID:14043-1738846800-1738850400@cpdd.org
SUMMARY:"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 1)
DESCRIPTION:"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 1) \n"Emerging adults aged 16–25 face heightened risks of opioid use disorder (OUD) and fentanyl-related overdoses. Although medications for opioid use disorder (MOUD) are effective for long-term management\, emerging adults often encounter significant challenges\, including unmet needs in employment\, housing\, and social support. These difficulties are further combined with life transitions\, such as establishing independence\, pursuing vocational growth\, and fostering stable relationships\, along with risks of high rates of co-occurring mental health issues and polysubstance use\, which can complicate recovery efforts. Despite these challenges\, very few research studies have addressed the unique recovery needs of this population. \nThis forum series offers a platform for meaningful dialogue on how to best support emerging adults in their recovery journeys. Participants will have the opportunity to learn from and collaborate with experts\, young adults with lived experience\, and researchers. Part 1 of this virtual series features a comprehensive discussion on key care principles for emerging adults' recovery\, grounded in an in-depth article review." \nTo Register:  https://www.jeapinitiative.org/ea-recovery-support-forums/ \nQuestions:  jeap@chestnut.org
URL:https://cpdd.org/event/whats-emergent-in-emerging-adult-recovery-support-services-research-forum-series-part-1/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250212T123000
DTEND;TZID=America/New_York:20250212T140000
DTSTAMP:20260405T004042
CREATED:20241230T170916Z
LAST-MODIFIED:20241230T170916Z
UID:13976-1739363400-1739368800@cpdd.org
SUMMARY:
DESCRIPTION:NABR Webinar: “The FY 2024 USDA Oversight Process”  \nPlease join us on Jan. 14\, 2025\, at 12:30 p.m. EST for the first of NABR’s 2025 Webinar series\, “The FY 2024 USDA Oversight Process.” Each year NABR obtains information from the USDA’s Animal Care Inspection System database using the Public Search Tool to review the inspection results for the previous fiscal year and provides a review and analysis of that information. The Public Search Tool was updated in September 2020 and now also contains information on enforcement actions including letters of warning and stipulation agreements. A preliminary review of the data using the Public Search Tool shows that the number of inspections conducted in FY 2024 was in line with the number conducted in FY 2023\, but the total number of noncritical\, critical and repeat citations decreased. In this webinar we will present our annual review of the inspection data along with an analysis of the type of noncompliant items cited and the enforcement actions taken as result of certain citations issued. \nRegister at this link:  https://register.gotowebinar.com/register/3774571084692246358 \n 
URL:https://cpdd.org/event/13976/
END:VEVENT
END:VCALENDAR